Abstract
Following the intraperitoneal administration of L-3-O-14C-methyl-4-hydroxyphenylalanine (14C-3-o-methyldopa; 14C-OMD), to rats, 15-20% of the injected radioactivity appeared in the expired air as 14C-CO2 over a period of 3-4 days; 65% of the dose was excreted in the urine and 8% in the faeces. When the experiments were repeated in rats with biliary fistulae, 20% of the dose was excreted in the bile in the first 24 hours, and there was no longer any detectable 14C-CO2 in the expired air. These studies establish that 3-o-methyldopa is demethylated in rats in vivo and that the demethylation occurs mainly in the gut.
| Original language | English |
|---|---|
| Pages (from-to) | 1243-1251 |
| Number of pages | 9 |
| Journal | Life Sciences |
| Volume | 10 |
| Issue number | 21, Part 1 |
| DOIs | |
| Publication status | Published - 1 Nov 1971 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Demethylation of 3-O-methyldopa in the rat'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver